retatrutide triple receptor agonist Retatrutide, an investigational hormone that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and The power of three: Retatrutide's

Combination Rationale Research has shown that combining amylin analogues with GLP-1 receptor agonists produces synergistic weight loss effects that exceed either agent alone

Beard on the cheek, but not on the neck, grew back (Figure 5)

Anjan Chatterjee told me that there just arent enough studies of these drugs in normal people. He said, In the situations where they do help, do they come with a cost? As he wrote in a recent letter to Nature , Most seasoned physicians have had the sobering experience of prescribing medications that, despite good intentions, caused bad outcomes. Given that cognitive enhancement is a choice, not a necessity, the cost-benefit calculation for neuroenhancers should probably be different than it is for, say, heart medications

Cross-reactivity, the phenomenon where a test antibody binds to an unintended molecule, requires structural similarity between the intended target and the unintended compound

Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence